Vascular Disease Management
INSIGHT INTO DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE
MANAGEMENT
Friday, August 29, 2008

SEARCH ARTICLES



Home | About
Current Issue
Archives
Subscribe
Board Members
Search Article Archives
Editor's Update
Events & Symposia
Industry News | Enews
Discussion Forum
Classifieds
Letter to the Editor
Comments/Suggestions
Editorial/Production
Author Information
Submit a Manuscript
Review a Manuscript
Reprints, Rights, Permission and Translation
Advertising
Advertising Specs
Online/Web Production

Featured Article

868
Vascular Disease Management - ISSN: 1553-8036 - Volume 5 - Issue 2 - March 2008
*Edwin Rodriguez-Cruz, MD, §Nara Matos-Hernandez, MD, §Amalys Montanez-Leduc, MD
1,2,3Mohsen Sharifi, MD, 2Mahshid Mehdipour, 1David Skloven, MD, 1Neil Kramer, MD, 1Alphonse Ambrosia, DO, 3Mark Starling, MD
Venous thromboembolism (VTE) is a grossly underdiagnosed disease associated with high mortality and morbidity. Despite tremendous advances in the interventional field, no significant changes have occurred on a wide scale in the approach to this entity over the last few decades. We report a 52-year-old man with massive bilateral lower extremity deep venous thrombosis extending into the inferior vena cava who underwent power-pulse spray with tissue plasminogen activator and Angiojet thrombectomy, leading to the rapid resolution of symptoms. We would like to use this case to call for a “paradigm shift” in the approach to VTE amongst endovascular specialists and recommend an early aggressive pharmacomechanical approach to its treatment.
1Matthew Nunnelley, MD, 1Michael Balk, MD, 2Dongming Hou, MD, 1Jack P. Chen, MD
Anomalous coronary arteries are rare angiographic findings, especially during acute myocardial infarction (MI). We present the first case of simultaneous-kissing-stent deployment in an anomalous coronary (left circumflex/obtuse marginal bifurcation with 360? loop) during an acute MI. Subsequently, staged transradial stenting of the left anterior descending artery was performed. This procedure, likewise, has not been previously described. Our case simultaneously illustrates the feasibility of both transfemoral and transradial approaches for anomalous coronary intervention in the same patient. The epidemiology and pathophysiology of anomalous coronary arteries are reviewed, with emphasis on anatomic classifications, as well as their associated cardiac mortality risks.

Management of Femoropopliteal Occlusive Disease in the Endovascular Era
Jeffrey Kalish, MD and Frank Pomposelli, MD
David E. Allie, MD
Frank. J. Criado
Usman Jaffer, MD, Abdul Wahab Elmagrabi, MD, Alan Cameron, MD, Isamuddin Osman, MD
Accurate ABPI measurement is fundamental to the community management of suspected peripheral arterial occlusive disease. This study investigates the correlation and agreement of GP performed ABPI measurements in the community compared to those measured in the vascular laboratory (VL) in the setting of a UK district general hospital. Records of 127 patients attending vascular clinic were reviewed, of whom 25 patients (19.69%) were referred by GPs with ABPI measurements performed. From these, 47 ABPI measurements were available and had limbs assessed by both GPs and VLs. For GP ABPI assessment: mean=0.748, median= 0.780, range=0.39 to 1.14, SD=0.200. For VL ABPI assessment: mean= 0.875, median=0.880, range=0.50 to 1.40, SD=0.245. GP performed measurement were an average of -0.13 (95% CI: -0.19 to -0.06, p = 0.0003), confirmed by Bland-Altman analysis. Using a diagnostic threshold of 0.9 for the GP performed ABPI, sensitivity=96 %, specificity=45.5%, PPV=66.7%, NPV=90.9% and accuracy=72.3
*Ramil Goel, MD, §Carol Hatler, PhD, RN, §Richard Heuser, MD
Background. Atrial arrhythmias have been linked to patent foramen ovale (PFO) and in many cases, arise after the operative closure of the PFO. The intention to decrease the frequency of cerebrovascular accidents with operative closure of PFOs is compromised and negated to some extent due to the induction of atrial fibrillation postoperatively. With percutaneous closure of PFOs gaining acceptability as an effective, noninvasive method of closure for PFOs, the effect of this closure technique on atrial arrhythmias and other postprocedure complications needs to be evaluated. Methods and results. We studied a series of 68 consecutive patients (age 55.74 + 14.74, 67.6% male) who underwent percutaneous closure of their PFOs performed between the years 2002–2007 at a single cardiac center. Four patients had atrial fibrillation preprocedure. After the procedure, 3 of these patients (age 57 + 16.46 years, 100% male) experienced resolution of their atrial fibrillation, and 1 remain

VASCULAR TOPICS

Peripheral Angioplasty
Thoracic Stent Grafts
Renal Stenting
Vena Cava Filter
Hemodialysis Management
Computed Tomography
PFO Closure
SFA Stenting
Carotid Stenting
Vessel Closure
Angiography
Carotid Endarterectomy
Ultrasound

Critical Limb Ischemia
Superficial Femoral Artery
Embolization
Device Based Thrombectomy
Pharmacological Management
MRA
Mesenteric Artery Stenting
AAA Stent Grafts
Iliac Stenting
Thrombolysis Procedures Using Drug Therapy

SUPPLEMENTS

Superior Mesenteric Artery Revascularization and Retrograde Visualization
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.

HMP Increased Cutaneous Sensibility in Patients with Diabetic Neuropathy Utilizing a Pharmacological Approach — Clinical Case Evidence

This clinical case update was supported through an unrestricted educational grant from Pamlab, LLC.

A New Biological Approachto Below-Knee Revascularization
A Review of the GORE PROPATEN Vascular Graft:
The Combination That Lasts

This special supplement was made possible through a grant from W. L. Gore

Combining Bilayered Living Cell Therapy with Minimally Invasive Vein Surgery:
Current Treatment Strategies for Venous Ulcers

This activity is supported by an educational grant from Organogenesis.

Pharmacotherapy in Peripheral Vascular Disease

Platelet Inhibition in Critical Limb Ischemia and Peripheral Vascular Interventions
DAVID E. ALLIE, MD

An Overview of Pharmacotherapy during Percutaneous Peripheral Interventions of Thrombotic Lesions
NICOLAS W. SHAMMAS, MD, MS, FACC


The Important Properties of Contrast Media: Focus on Viscosity

This special supplement was made possible through a grant from Guerbet LLC

RECENTLY ADDED

Anticoagulation Techniques for Peripheral Vascular Interventions

Archived Webcast





About HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP’s products and services at www.hmpcommunications.com. ©2008 HMP Communications

© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd., Suite 100, Malvern, PA 19355
Phone: 800.237.7285 610.560.0500 Fax: 610.560.0502
Privacy Policy